{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Pyxis Oncology, Inc."},"Symbol":{"label":"Symbol","value":"PYXS"},"Address":{"label":"Address","value":"35 CAMBRIDGEPARK DRIVE, CAMBRIDGE, Massachusetts, 02140, United States"},"Phone":{"label":"Phone","value":"+1 617 221-9059"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion."},"CompanyUrl":{"label":"Company Url","value":"https://www.pyxisoncology.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Balu Balasubramanian","title":"Chief Technology Officer"},{"name":"Jan Pinkas","title":"Chief Scientific Officer"},{"name":"Ken Kobayashi","title":"Chief Medical Officer"},{"name":"Lara S. Sullivan","title":"President, Chief Executive Officer & Director"},{"name":"Pamela Yanchik Connealy","title":"Chief Operating & Financial Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}